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Summary
Objectives: To investigate associations between androgens (testosterone, dehydro-
epiandrosterone sulphate [DHEAS] and androstenedione), adiposity, fat distribution
and insulin resistance (IR) during childhood and adolescence.
Methods: Three hundred and seven children (170 [55.4%] boys; 137 [44.6%] girls)
recruited at age 5 and studied annually until age 16: androgens (liquid chromatogra-
phy tandem-mass spectrometry), anthropometry, body composition (dual-energy x-
ray absorptiometry) and IR (homeostasis model assessment).
Results: Early adiposity was associated with earlier detection of androstenedione in
both sexes, and DHEAS in boys. At puberty, higher androgen levels were associated
with favourable metabolic changes in boys, but adverse metabolic effects in girls. In
boys, higher free testosterone (FT) was associated with lower body fat and android/
gynoid fat ratio (AGR) (both P < .001), but in girls higher total testosterone was asso-
ciated with higher AGR. In girls only, higher androstenedione (P = .02) and FT
(P = .01) was associated with higher IR during puberty.
Conclusions: In pre-pubertal children, adiposity is associated with higher secretion of
androgen precursors. After pubertal onset, higher testosterone is associated with
lower adiposity and AGR in boys, but higher AGR and IR in girls. Therefore, andro-
gens have modest sex-specific associations with children's total body fat, fat distribu-
tion and IR.
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1 | INTRODUCTION
Differences in concentrations of androgen precursors (AP) and testos-
terone in children may have significant long-term implications for adi-
posity, fat distribution and insulin resistance (IR). However, most
previous research has been undertaken in children with adrenal
disorders or obesity, whereas healthy children have been less well
represented.
Before puberty, androgens are derived from adrenal AP, whereas
gonadal androgen production dominates after the onset of puberty.
The detection of AP, such as dehydroepiandrosterone sulphate
(DHEAS) and androstenedione, indicates adrenocortical activation
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(adrenarche),1 and there is some evidence from small and selective
studies that early adrenarche may be associated with IR and subse-
quent risks of type 2 diabetes and polycystic ovary syndrome.2,3 Fur-
thermore, AP also have been associated with obesity in pre-pubertal
children.4,5,6,7,8
Androgen concentrations change with age and development and
differ by sex. Indirect evidence suggests that gonadal androgen pro-
duction is also influenced by adiposity. Thus, increasing obesity has
been linked to declining age of puberty,9 and earlier menarche associ-
ated with adult obesity.10 Although early androgen production might
be associated with IR, obesity and long term metabolic risks,11,12 the
implications of AP and testosterone for fat distribution and IR in
healthy children without adrenal disorders have received little
attention.
Therefore, the aim of this longitudinal study was to investigate
whether AP and testosterone are associated with adiposity, fat distri-
bution and IR over time, in a healthy cohort of mainly normal weight
children without adrenal disorders. Four specific objectives were to
investigate: (a) The effect of adiposity on the onset of AP secretion;
(b) The effect of puberty and adiposity on androgen concentrations
over time; (c) The effect of puberty and androgen concentrations on
body fat and fat distribution over time; (d) The effect of androgen
concentrations on IR over time.
2 | METHODS
2.1 | The EarlyBird cohort
The EarlyBird study is an observational study investigating childhood
origins of diabetes and obesity. The present analysis focuses on the
potential role of androgens. Ethical approval was granted by Plym-
outh Local Research Ethics Committee in 1999 and updated regu-
larly. The study was conducted in accordance with the Declaration
of Helsinki and International Committee on Harmonisation of Good
Clinical Practice. Written consent from parents and assent from chil-
dren were obtained at each visit. The methodology has been
described.13 Three hundred and seven healthy children (170 boys)
age 5 were recruited from schools, sampled from high and low socio-
economic areas and followed up every year until age 16 (for a total
of 12 consecutive years). The exclusion criteria among the children
included: existing diabetes, pathological states likely to affect growth
or body composition, moderate or severe physical disability, and
long-term use of oral steroids. Another 40 children were subse-
quently recruited at age 9 and followed up every year until age 16
(for a total of 8 consecutive years), to compensate for withdrawals
and balance sexes. Data were collected annually from age 5 to 16
starting in the year 2000. There was 80% retention of the cohort at
age 16. Comparing characteristics at age 5 for the 78% of the origi-
nal cohort who were followed up at age 16 to the 22% that were lost
to follow up, showed no differences between the two groups in
body mass index (BMI) SD scores (SDS), index of multiple depriva-
tion (IMD) or height SDS in either sex.
2.2 | Clinical methods
Children attended after an overnight fast from 22.00 hours, and vene-
section was performed at 09.00 hours. Ethnicity and socio-demo-
graphics at age 5 (IMD 2004, free school meal entitlement of the
child, working hours, occupation, education level and income of the
parents) and medical history were recorded by a research nurse within
a hospital department of child health. Height was measured to the
nearest 1 mm in blind duplicate (Leicester Height Measure, Child
Growth Foundation, London, UK) and weight to the nearest 100 g
(Tanita bio-impedance scales, Tanita UK Ltd) every 6 months. Age-
adjusted BMI SDS were calculated with reference to 1990 UK stan-
dards.14 Age at peak height velocity (APHV) was used as the primary
measure of puberty, determined as tangential velocity at the middle
time-point of three consecutive height measurements recorded 6
months apart. Tanner stage was self-reported annually using simple
illustrations.15 Early menarche was defined as first menses
<11 years.16
Total body fat was determined by Dual-energy X-ray Absorp-
tiometry (DEXA) using the Prodigy Advance fan beam densitome-
ter (GE Healthcare, Chicago, IL) and fat distribution was
expressed as the android/gynoid fat ratio (AGR). Physical activity
was measured annually from age 5 by accelerometry (ActiGraph
[formerly MTI/CSA].17,18,19 Children wore accelerometers for
seven consecutive days at each follow-up, and only recordings
capturing at least four days were accepted. Time spent in
moderate-to-vigorous physical activity (MVPA) per day was
recorded as minutes spent in activity equivalent to three meta-
bolic equivalents (METs), that is, approximately 2500 ActiGraph
counts/min.20 The mean MVPA for each child (from age 9 to 16)
was reported.
2.3 | Laboratory methods
DHEAS, androstenedione, and total testosterone (TT) were mea-
sured in serum by liquid chromatography tandem-mass spectrometry
(LC-MS/MS) using the Waters Acquity Ultrahigh Performance Liquid
Chromatography System and Quattro Premier Tandem Quadrupole
Mass Spectrometry (Waters Corporation, MA). Assay CVs were
<15%. Free testosterone (FT) was calculated using the formula of
Vermeulen.21 All children at visit ages 5 to 8, 268 children at visit
age 9 and 71 children at visit age 10 had luteinizing hormone (LH)
measured by sandwich immunoassay. LH was measured by sandwich
immunoassay with the Siemens Centaur system (lower limit of
detection 0.5 IU/L). From April 2005, LH was measured by electro-
chemiluminescent assay with the Roche E170 system (lower limit of
detection 0.1 IU/L). Insulin was assayed by chemiluminescent
immunometric assay (DPC Immulite, Los Angeles, CA), in weekly
batches of frozen serum. The inter-assay CV was 8.0% at 2.87 mU/
L, lower detection limit 2.0 mU/L, and cross-reactivity with proinsu-
lin <1%. IR was calculated by homeostasis model assessment
(HOMA).22
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2.4 | Statistical methods
Data were analysed with the statistical programming language R.23
Boys and girls were modelled separately due to differences including
the timing of puberty. Non-normal continuous outcome variables
were logarithmically transformed if appropriate. A square root trans-
formation was applied to DHEAS in girls. Androgen levels were con-
sidered “detectable” if individuals' concentrations were measurable
for at least two consecutive years. Associations between age at
detection of androgens and early adiposity (ages 5-7) were analysed
with linear regression. Temporal relationships (from age 9) between
androgen levels, body fat, fat distribution and IR were investigated
with linear mixed effects models, using the lme4 package24 in R.
Imputation of missing data was not performed and any observations
with incomplete data for the variables of interest were not included
in the models. Individuals were not excluded if there were any miss-
ing time points. Associations between androgen levels, body compo-
sition and IR were examined with each of these variables in turn as
the dependent variable. Mixed-effects models were constructed for
boys and girls separately, with study visit (age) as repeat measure,
individual identity codes as random effects and other covariates as
fixed effects. For androgen levels as the dependent variable,
covariates tested for inclusion were age, APHV and total body fat;
for body fat/fat distribution as the dependent variable, covariates
tested for inclusion were age, APHV and androgen SDS; for IR as
the dependent variable, covariates tested for inclusion were age,
APHV, height SDS, fat distribution and minutes of MVPA per day.
APHV was also substituted with the age at self-reported Tanner
stage 2, 3 and 4 (each in turn) for each of the longitudinal models to
address any differences relating to the use of this single measure of
puberty. Androgen levels were represented as SDS when included
as covariates (because concentrations increased over time). Andro-
gen SDS were standardised for sex and visit age group. The signifi-
cance of candidate variables in linear regression and mixed-effects
models were tested through forward and backward stepwise selec-
tion at 5% significance levels. Normality assumptions for linear and
mixed effects models were checked visually using quantile-quantile
plots. Outliers that influenced model assumptions (ie, data points
that have a large effect on the slope of the regression line) were
removed from analyses (if they did not affect the overall conclusion).
Where interactions of factorial and continuous variables were mod-
elled, effects such as age and BMI SDS were interpreted graphically
by choosing approximately the 25th, 50th and 75th percentiles of
the continuous variable and plotting the predicted outcome against
the time factor for these reference levels.
3 | RESULTS
There were 3439 (1795 [52.2%] boys; 1644 [47.8%] girls) observa-
tions available between ages 5 and 16. 98% of the cohort were Cau-
casian with five children of mixed race. At age 5, the mean (95%
confidence interval) IMD score in boys was 25.1 (23.0, 27.2)
compared to 27.4 (24.8, 30.0) in girls (Table 1). At age 5, the mean
(95% confidence interval) BMI SDS in boys was 0.19 (0.03, 0.35) com-
pared to 0.53 (0.37, 0.69) in girls (Table 1). There were 2116 (1073
[50.7%] boys; 1043 [49.3%] girls) observations with DEXA data avail-
able between ages 9 and 16—in every model at least 70% of these
observations were maintained.
3.1 | The effect of adiposity on the onset of
androgen precursors and testosterone
The mean (95% confidence interval) age at androstenedione detec-
tion was 7.2 (6.9, 7.5) and 8.0 (7.6, 8.4) years in girls and boys
respectively (Table 1). Androstenedione levels increased over time
and by age 16 were higher in girls than boys (mean [95% confidence
interval] 121.1 [110.9, 131.4] vs 84.4 [80.1, 88.6] nmol/l; P < .001)
(Figure 1A). Mean (95% confidence interval) age at DHEAS detec-
tion was approximately 8 years in both sexes (Table 1)—girls 7.7
(7.4, 8.1) vs boys 7.7 (7.4, 8.0) and by age 16, concentrations were
marginally higher in boys than girls (mean [95% confidence interval]
140.6 [129.8, 151.4] vs 125.2 [114.2, 136.3] nmol/L; P = .052) (Fig-
ure 1B). LH was detected in both sexes at approximately 11 years—
girls 11.3 (11.1, 11.4) vs boys 11.3 (11.1, 11.5). TT was undetectable
before 9 years, and became detectable at approximately 12 years
(Figure 1C, D) in both sexes (Table 1)—girls 12.2 (11.9, 12.5) vs boys
12.1 (11.9, 12.3). Ages at androgen detection are summarised in
supplementary file 1. Six girls had early menarche (first menses
<11 years16). Three children had undetectable TT at 16 years (2
girls, 1 boy).
3.1.1 | Androstenedione
In boys, androstenedione detection age was weakly associated with
BMI SDS at 6 years (r = −0.15, P = .07). The association was signifi-
cant at 7 years (r = −0.20, P = .009), when a one-unit higher BMI SDS
was associated with 5.7% (1.5%, 9.8%) or 8 months earlier andro-
stenedione detection by age 12. In girls, BMI SDS at 5-7 years was
also associated with age at androstenedione detection (r = [−0.19,
−0.19, −0.22]; P = [.054, .047, .016]). For example, a one-unit higher
BMI SDS at age 6 (r = −0.19, P = .047) was associated with 4.8%
(0.1%, 9.3%) or approximately 7-month earlier androstenedione
detection by age 12.
3.1.2 | Dehydroepiandrosterone sulphate
Higher BMI SDS at 5-7 years was associated with earlier DHEAS
detection in boys (r = [−0.21, −0.21, −0.23]; P = [.03, .03, .01]) but not
girls (r = [−0.15, −0.12, −0.09]; P = [.24, .21, .32]). In boys, a one-unit
higher BMI SDS at age 5 (r = −0.21, P = .03) was associated with 4.0%
(0.4%, 7.5%) or just under 6 months earlier DHEAS detection by
age 12.
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3.1.3 | Total testosterone
Detection age was investigated using TT. In boys, between 5 and
7 years, there were no associations between BMI SDS and TT detec-
tion age (r = [0.002, 0.03, −0.05]; P = [.44, .44, .99]). In girls, there was
a borderline association at 5 years (r = −0.13, P = .06) but none at 6-
7 years (r = [−0.07, −0.04]; P = [.17, .29]). However, in girls BMI SDS
at 5-7 years was associated with earlier detection of LH (r = [−0.25,
−0.27, −0.29]; P = [.006, .005, .003]). A one-unit higher BMI SDS at
5 years (r = −0.25, P = .006) was associated with approximately () 3-
months (1.5, 4.5) earlier LH detection. In boys, BMI SDS was not
associated with age at LH detection.
TABLE 1 Characteristics of the original cohort at age 5
Boys (N = 170) Girls (N = 137) P-value























N (%) 16 (9.4) 17 (12.4) .34
Obese
N (%) 7 (4.1) 7 (5.1) .68
























































































Abbreviations: AD, androstenedione; APHV, age at peak height velocity; DHEAS, dehydroepiandrosterone sulphate; LH, luteinizing hormone; IMD, index
of multiple deprivation; SDS, SD score.






































































































F IGURE 1 Boxplots of androgen precusors and free testosterone (separated by sex) for ages 5 to 16 years A-D; total body fat and android
gynoid fat mass ratio (separated by sex) for ages 9 to 16 years E-F
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3.2 | The effect of puberty and adiposity on
androgen concentrations over time
The primary analysis presented here and in Sections 3.3 and 3.4 was
undertaken using APHV as the measure of puberty. The analysis was
also undertaken using self-report Tanner stage as the measure of
puberty. The findings were similar, and any differences are
highlighted. The results are shown in Table 2. In both sexes, andro-
stenedione concentrations were associated with age, earlier APHV
and lower body fat by 16 years (Table 2). In boys, DHEAS concentra-
tions were also associated with age and earlier APHV (Table 2). Two
outliers (both age 15) were removed from the model due to their
effect on the normality assumption and the results are shown in
Table 2 (the findings remained significant with these outliers
maintained in the model). In girls, DHEAS was associated with age,
earlier APHV and higher body fat; for example, an increase in body fat
from 25% to 35% in girls at age 12, with an average APHV of 12, was
associated with approximately 5.7 ng/dL higher DHEAS (Table 2).
In both sexes, FT was associated with age, APHV, body fat and
there were interaction effects with age for APHV and body fat. In
boys, FT concentrations increased between 9 and 16 years, with a
substantial increase in the rate of change by 13 years, and were asso-
ciated with earlier APHV and lower body fat (Figure 2A, B). In girls, FT
was associated with earlier APHV but higher body fat (Figure 2C, D).
The findings above were consistent when age at self-reported Tanner
stage 2, 3 or 4 was used as the measure of puberty but the interaction
effect with age and body fat was no longer statistically significant in
girls (P = .07; P = .08; P = .15 respectively).
3.3 | The effect of puberty and androgen
concentrations on body fat and fat distribution
over time
Results are shown in Figure 3.
3.3.1 | Androstenedione
Androstenedione SDS was unrelated to body fat (P = .20 boys; P = .99
girls). In boys, androstenedione SDS was unrelated to AGR (P = .11).
In girls, however, AGR was predicted by age (P = .06), APHV (P = .14),
androstenedione SDS (P = .001), and interaction effects of age with
APHV (P = .02) and androstenedione SDS (P < .001). Androstenedione
SDS was associated with lower AGR at age 9, but higher AGR by
16 years (Figure 3A).
TABLE 2 Longitudinal mixed effects modelling results
Boys
Androstenedione (n = 759) DHEAS (n = 834) Free testosterone (n = 776)
Predictor Coefficient SE P-value Coefficient SE P-value Coefficient SE P-value
Intercept −2.86 1.43 .05 −10.92 3.96 .006 −179.20 16.02 <.001
age 0.62 0.11 <.001 2.11 0.21 <.001 30.05 2.60 <.001
age2 −1.17 0.10 <.001
APHV 0.16 0.11 .14 0.59 0.30 .05 12.39 1.20 <.001
body fat 0.05 0.009 <.001 −0.01 0.004 .008
age: APHV −0.02 0.008 .009 −0.09 0.02 <.001 −2.15 0.20 <.001
age2: APHV −0.09 0.008 <.001
age: body fat −0.004 0.0007 <.001
Girls
Androstenedione (n = 794) DHEAS (n = 802) Free testosterone (n = 795)
Predictor Coefficient SE P-value Coefficient SE P-value Coefficient SE P-value
Intercept 3.07 1.19 .01 −7.68 2.82 .007 −29.66 7.20 <.001
age 0.23 0.09 .01 1.67 0.17 <.001 4.92 1.17 <.001
age2 −0.20 0.05 <.001
APHV −0.35 0.10 <.001 0.39 0.24 .10 2.05 0.58 <.001
body fat 0.07 0.01 <.001 0.04 0.01 <.001 −0.13 0.08 .09
age: APHV 0.02 0.007 .03 −0.07 0.01 <.001 −0.39 0.09 <.001
age2: APHV 0.02 0.004 <.001
age: body fat −0.005 0.001 <.001 0.03 0.01 .04
age2: body fat −0.001 0.0005 .03
Note: Androstenedione and free testosterone was transformed with the natural logarithm in both sexes. DHEAS had a square root transformation applied
in both sexes. Sample size is the number of observations available between ages 9 and 16.
Abbreviations: APHV, age at peak height velocity; DHEAS, dehydroepiandrosterone sulphate.
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3.3.2 | DHEAS
In boys, DHEAS SDS was unrelated to body fat (P = .18). In contrast,
in girls, higher DHEAS SDS was associated with body fat. Body fat
was predicted by age (P = .70), APHV (P = .07), DHEAS SDS (P < .001)
and the interaction of age with APHV (P = .009). On average, a one-
unit increase in DHEAS SDS was associated with approximately a 1%





















































































































F IGURE 2 Interaction plots from longitudinal mixed effects models for age at peak height velocity (APHV) A and C, and total body fat B and
D, when free testosterone concentration is an outcome for boys A and B, and girls C and D, separately between ages 9 and 16
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In boys, DHEAS SDS was positively associated with AGR, with
age, FT SDS and their interaction effect (see section on FT below) in
the model. In contrast, DHEAS SDS in girls was not associated with
AGR (P = .31).
3.3.3 | Free testosterone
In boys, from age 11, FT SDS was inversely associated with body fat
































































F IGURE 3 Interaction plots from longitudinal mixed effects models for androstenedione SD scores (SDS) A, total testosterone SDS B, and
free testosterone SDS C and D, when android gynoid fat mass ratio A, B, D, or total body fat C, is an outcome for girls A and B, and boys C and D,
separately between ages 9 and 16
8 of 13 CHYNOWETH ET AL.
interaction (all P < .001). DHEAS SDS was not correlated with FT SDS
so was therefore added into the model. AGR in boys was predicted by
age (P = .055), DHEAS SDS (P < .001), FT SDS (P = .001) and the inter-
action between age and FT SDS (P = .001) (Figure 3D). In contrast, in
girls, body fat had no association with FT SDS when age and APHV
were included (P = .098). AGR was predicted by age and FT SDS (both
P < .001). On average, a one unit increase in FT SDS was associated
with an increase in android fat mass of 18 g/cm2 (683 to 701 units
when age = 12 and FT SDS increases from 0 to 1).
TT had similar effects to FT in both sexes for body fat and
AGR in boys. The exception was that in girls from age 13, TT SDS
was associated with higher AGR. AGR was predicted by age
(P < .001), TT SDS (P = .04) and their interaction (P = .03)
(Figure 3B).
3.4 | The effect of puberty, fat distribution,
height, MVPA and androgen concentrations on IR
over time
Before including androgens, IR in boys was predicted by age
(P < .001), APHV (P = .003), height SDS (P < .001), AGR (P < .001),
MVPA (P = .04), and the interaction of age with APHV (P < .001).
Holding all other terms constant (age = 12, APHV = 12, height
SDS = 0, MVPA = 20 minutes per day and an android fat mass of
600 g/cm2 for a gynoid fat mass of 2000 g/cm2 (ie, an AGR of
0.3): in boys, on average an increase in android fat mass of 200 g/
cm2 was associated with 24.4% increase in IR (0.93 to 1.16 IR
units), and a one-unit increase in height SDS with 11.6% higher IR
(0.93 to 1.04 IR units). Ten-minutes more MVPA per day was
associated with 3.0% lower IR (0.93 to 0.90 IR units). At 10 and
14 years, IR was similar in boys regardless of APHV. However, at
approximately 12 years, boys with earlier APHV exhibited higher
IR. In contrast, by age 16, later APHV was associated with higher
IR. Thus, at 12 and 16 years, 1-year increases in APHV were asso-
ciated with 5.1% lower and 27.8% higher IR (0.93 to 0.88 IR units
and 0.39 to 0.49 IR units). In girls, IR was predicted by age, height
SDS and AGR (all P < .001). Keeping all other terms constant (as
for boys), a one-unit increase in height SDS was associated with
25.1% higher IR (1.04 to 1.31 IR units), and a 200 g/cm2 increase
in android fat mass was associated with 24.7% higher IR (1.04 to
1.30 IR units).
3.4.1 | Androstenedione
Results are shown in Figure 4. In boys, there was no association
between IR and androstenedione SDS (P = .97) (Figure 4A). In con-
trast, in girls, IR was predicted by age (P < .001), AGR (P < .001),
height SDS (P < .001), androstenedione SDS (P = .02), the interaction
of age with androstenedione SDS (P = .008), and the magnitude in the
pubertal peak in IR was associated with higher androstenedione SDS
(Figure 4B).
3.4.2 | DHEAS
There were no associations between IR and DHEAS SDS in boys or
girls (P = .52 and P = .50 respectively).
3.4.3 | Testosterone
There was a marked sex difference in the relationship between FT and
IR, and findings were similar with TT. In boys, there was no association
between FT SDS (P = .46) and IR (Figure 4C). The findings above were
consistent when age at self-reported Tanner stage was used as the mea-
sure of puberty. The interaction effect with age and FT SDS was not
statistically significant when APHV was used as the measure of puberty
but became statistically significant when Tanner stage 2-3 was used
(both P = .01). In contrast, in girls, IR was predicted by age (P < .001),
AGR (P < .001), height SDS (P < .001), FT SDS (P = .01) and the interac-
tion of age with FT SDS (P = .007). In girls, the relationship between FT
and IR changed over time, and the magnitude of the pubertal peak in IR
at approximately age 12 was associated with higher FT SDS (Figure 4D).
However, by age 16, the relationship between FT and IR in girls was not
significant. When age at self-reported Tanner stage 4 was used as the
measure of puberty, the interaction effect with age and FT SDS was no
longer statistically significant in girls (P = .12).
4 | DISCUSSION
These data show that elevated androgen levels in childhood are associ-
ated with significant but small differences in adiposity, fat distribution
and IR. These associations differ in girls and boys. In girls, the associa-
tions of higher androstenedione and testosterone with higher AGR and
IR during puberty lie in the direction of increased cardiometabolic risk,
whereas in boys higher testosterone was associated with lower AGR
and no impact on IR. The contrasting relationship of androgens with
body fat in boys and girls may be explained by differences in peripheral
and central effects. The peripheral lipolytic effects of high testosterone
concentrations in boys may reduce body fat. However, central effects
may also be suggested by evidence that higher adiposity in boys is asso-
ciated with later puberty25 and relative hypogonadism.26
While it is thought that AP may influence fat distribution and IR,
most previous work was undertaken in children with adrenal disor-
ders, and so relevance to normal development is uncertain. Adre-
narche is associated with higher expression of adrenocortical
steroidogenic enzymes.27 Recent research suggests this is a gradual
process.28 The absence of adrenarche in children with adrenocortico-
tropic hormone (ACTH) receptor mutations29 and hypopituitarism30
suggests that ACTH is required for adrenocortical activation. How-
ever, nutrition-related signals including insulin, IR, growth hormone/
insulin-like growth factor 1 and leptin also influence adrenocortical
development.1 Consistent with this, higher infant adiposity and height
were associated with premature adrenarche.31 Therefore, nutritional
influences may explain why premature adrenarche is associated with
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higher weight and metabolic risks. The present results, in a cohort of
healthy children, show that early adiposity (ages 5-7) is associated
with higher AP production during normal development.
This study also demonstrated that higher concentrations of AP
and testosterone were associated with earlier puberty. The findings
were consistent with APHV or Tanner stage as the measure of
puberty, with some sex differences. In girls, when age at self-reported
Tanner stage 2, 3 or 4 was used instead of APHV (when modelling
testosterone concentrations) the interaction of age with adiposity was
no longer significant, suggesting that Tanner stage may be associated
with testosterone concentrations, as might be expected. In boys,




































































F IGURE 4 Interaction plots from longitudinal mixed effects models for androstenedione SD scores (SDS) A and B, and free testosterone SDS
C and D, when insulin resistance (HOMA-IR) is an outcome for boys A and C, and girls B and D, separately between ages 9 and 16
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whether APHV or Tanner stage was the measure of puberty. The find-
ings with IR were consistent with APHV or Tanner stage as the mea-
sure of puberty in girls. The changes in IR in boys were explained by
APHV and Tanner stage 4, but not Tanner stage 2 or 3. When Tanner
stage 4 was used as the measure of puberty in girls, the interaction of
age with testosterone was no longer associated with IR, suggesting
that Tanner stage 4 may be associated with IR.
There are several reasons why AP might accelerate pubertal pro-
cesses. In a previous study, higher early pubertal concentrations of
androstenedione and estradiol were associated with faster pubertal
development.32 Although biologically inactive, AP are minimally bound
by sex hormone-binding globulin,33 and conversion to dihydrotestos-
terone or estradiol could be significant. Furthermore, adipose tissue
metabolises sex steroids. For example, intracellular aromatisation of
AP to estrone in adipose tissue34 and subsequent conversion to estra-
diol35 could associate adiposity with higher estradiol production. Adi-
pose tissue can also generate and inactivate testosterone.36
Therefore, not only can nutritional signals activate the adrenal cortex,
but also adiposity amplifies and enhances sex steroid effects.
It is recognised that the present study has both strengths and lim-
itations. The study builds on previous advances. The high sensitivity
of isotope dilution gas chromatography mass spectrometry has
advanced the study of androgens in children,37 and is well suited to
detecting low steroid concentrations. Androgen levels measured by
LC-MS in children were reported by Meikle et al38 and reference
ranges reported elsewhere.39,40,41 The findings of higher concentra-
tions of DHEAS and testosterone in boys and androstenedione in
girls, support previous observations.41 The key strength of this study
was the EarlyBird cohort itself, with high retention rate, and meticu-
lous year-on-year measurements of growth, pubertal development,
anthropometry, body composition, and endocrinology in contempo-
rary British children.
The principal limitation is that while a cohort study can demon-
strate association and temporal precedence, it does not prove causa-
tion. For example, the association of higher androgens with central
adiposity during puberty in girls could have several explanations,
including that obesity-related IR stimulates ovarian androgen produc-
tion,42 as well as the possibility that androgens might promote central
adiposity in girls. Other potential limitations include the sample size
(especially before age 11 when most children have undetectable tes-
tosterone), relatively lean population, and some children (particularly
boys), had not completed puberty by age 16 when measurements
stopped. Due to the lack of ethnic diversity in South West England,
the cohort is limited to mostly white ethnic backgrounds therefore
these data may not be generalisable to other ethnicities. There is also
error in estimating age at detection of androgens and LH because of
annual sampling. The less sensitive assay for LH was used until 2005,
which limits the ability to determine the age at which LH was first
detected in children with early puberty.
The analysis was strengthened by the availability of both APHV and
self-reported Tanner stage reflecting growth hormone and sex steroid
action spanning puberty. Tanner stage was self-reported to avoid
repeated intimate physical examinations in adolescents. A benefit of
Tanner stage is that it reflects a process over time, but drawbacks were
its subjectivity, not being specific enough to differentiate between Tan-
ner stages, sex difference and the variable stage reached by age
16 years. For example, only 197 out of 270 children (73%) reported at
age 16 considered themselves to have reached Tanner stage 4, which
substantially decreases the sample size for this measure. In contrast,
APHV is a single time point but is an objective measure. It is noted that
APHV occurs later in puberty for boys compared to girls, which is why
girls and boys were modelled separately. The principal results of the
study were the same, irrespective of whether puberty was measured by
APHV or Tanner stage.
In conclusion, these data show that androgens contribute to the
regulation of body weight and fat distribution in children. AP and testos-
terone have modest but significant effects on adiposity and fat distribu-
tion, with important sex contrasts. Higher androgen levels appeared to
have potentially adverse effects on fat distribution and metabolism in
girls and favourable effects in boys. However, it remains uncertain
whether or not physiological differences in androgen concentrations in
childhood lead to long-term differences of fat distribution and IR in
adults. Longer-term studies may answer that question.
ACKNOWLEDGEMENTS
The EarlyBird study was the idea of our former colleague Professor
Terry Wilkin (1945-2017), Professor of Endocrinology and Metabo-
lism at the Peninsula College of Medicine and Dentistry in Plymouth.
Terry designed and directed this study for many years. We gratefully
acknowledge Terry's life work and key contributions to this paper. We
also acknowledge the contribution made by Dr Linda Voss, study co-
ordinator from 1999 to 2012, and other members of the EarlyBird
team. The EarlyBird study was supported by the Bright Future Trust,
the Kirby Laing Foundation, the Peninsula Foundation and the
EarlyBird Diabetes Trust.
CONFLICT OF INTEREST




1. Belgorosky Bacquedano MS, Gercio G, Rivarola MAA. Adrenarche:
postnatal adrenal zonation and hormonal and metabolic regulation.
Horm Res. 2008;70:257-267.
2. Ibanez Dimartino-Nardi J, Potau N, Saenger PL. Premature adre-
narche: normal variant or forerunner of adult disease? Endocr Rev.
2000;21:671-696.
3. Utriainen Laakso S, Liimatta J, Jaaskelainen J, Voutilainen RP. Prema-
ture adrenarche—a common condition withb variable presentation.
Horm Res Paediatr. 2015;83:221-231.
4. Remer Manz FT. Role of nutritional status in the regulation of adre-
narche. J Clin Endocrinol Metab. 1999;84:3936-3944.
5. Corvalan Uuay R, Mericq VC. Obesity is positively associated
with dehydroepiandrosterone sulfate concentrations 1 to 7 y in
Chilean children of normal birth weight. Am J Clin Nutr. 2013;97:
318-325.
CHYNOWETH ET AL. 11 of 13
6. Pintor Loche S, Faedda A, Fanni V, Nurchi AM, Corda RC. Adrenal
androgens in obeses biys before nad after weight loss. Horm Metab
Res. 1984;16:544-548.
7. Akyurek Atabek ME, Eklioglu BS, Alp HN. Is there a relationship
between cardiovascualr risk factors and dehydroepiandrosterone sul-
fate levels in childhood obesity? J Pediatr Endocrinol Metab. 2015;28:
545-550.
8. Mantyselka Jaaskelainen J, Lindi V, Viitasalo A, Tompuri T,
Voutilainen R, Lakka TAA. The presentation of adrenarche is sexually
dimorphic and modified by body adiposity. J Clin Endocrinol Metab.
2014;99:3889-3894.
9. Biro M, Greenspan LC, MPF G. Puberty in girls of the 21st century. J
Pediatr Adolesc Gynecol. 2012;25:289-294.
10. Prentice Viner RMP. Pubertal timing and adult obesity and
cardiometablic risk in woemn and men: a systematic review and
meta-analysis. Int J Obes. 2013;37:1036-1043.
11. Kousta E. Premature adrenarche leads to polycystic ovary syndrome?
Long term consequences. Ann N Y Acad Sci. 2006;1092:148-157.
12. Janghorbani Mansourian M, Hosseini EM. Systematic review and
meta-analysis of age at menarche and risk of type 2 diabetes. Acta
Diabetol. 2014;51:519-528.
13. Voss LD, Kirkby J, Metcalf BS, et al. Preventable factors in childhood
that lead to insulin resistance, diabetes mellitus and the metabolic
syndrome: the EarlyBird diabetes study 1. J Pediatr Endocrinol Metab.
2003;16(9):1211–1224. https://doi.org/10.1515/JPEM.2003.16.9.
1211.
14. National Obesity Observatory. A simple guide to classifying body mass
index in children. http://www.noo.org.uk/uploads/doc/vid_11601_A_
simple_guide_to_classifying_BMI_in_children.pdf. Published 2011.
15. Taylor SJC, Whincup PH, Hindmarsh PC, Lampe F, Odoki K,
Cook DG. Performance of a new pubertal self-assessment question-
naire: a preliminary study. Paediatr Perinat Epidemiol. 2001;15(1):88-
94. https://doi.org/10.1046/j.1365-3016.2001.00317.x.
16. Gaudineau A, Ehlinger V, Vayssiere C, Jouret B, Arnaud C, Godeau E.
Factors associated with early menarche: results from the French
Health Behaviour in School-aged Children (HBSC) study. BMC Public
Health. 2010;10:175.
17. Metcalf BS, Curnow JS, Evans C, Voss LD, Wilkin TJ. Technical reli-
ability of the CSA activity monitor: the EarlyBird Study. Med Sci Sport
Exerc. 2002;34(9):1533-1537. https://doi.org/10.1249/01.MSS.0000
027715.99037.06.
18. Puyau MR, Adolph AL, Vohra FA, Butte NF. Validation and calibration
of physical activity monitors in children. Obes Res. 2002;10(3):150-
157. https://doi.org/10.1038/oby.2002.24.
19. Fox KRC. Start Active, Stay Active: A Report on Physical Activity for
Health from the Four Home Countries' Chief Medical Officers. Rich-




20. Schmitz KH, Treuth M, Hannan P, et al. Predicting energy expenditure
from accelerometry counts in adolescent girls. Med Sci Sport Exerc.
2005;37(1):155-161. https://www.ncbi.nlm.nih.gov/pubmed/156
32682.
21. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple
methods for the estimation of free testosterone in serum. J Clin
Endocrinol Metab. 1999;84(10):3666-3672. https://doi.org/10.1210/
jcem.84.10.6079.
22. Matthews DR, Hosker JR, Rudenski AS, Naylor BA, Treacher DF,
Turner RC. Homeostasis Model Assessment: Insulin Resistance and Fl-
Cell Function from Fasting Plasma Glucose and Insulin Concentrations in
Man. Vol 28. Berlin, Germany: Springer Science+Business Media;
1985. https://link.springer.com/content/pdf/10.1007/BF00280883.
pdf. Accessed July 16, 2019.
23. R Core Team. R: A language and environment for statistical comput-
ing. https://www.r-project.org/. Published 2017.
24. Bates D, Bolker B, Walker S, Machler M. Fitting linear mixed-effects
models using lme4. J Stat Softw. 2015;67(1):1-48. https://doi.org/10.
18637/jss.v067.i01.
25. Vandewalle S, Taes Y, Fiers T, et al. Sex steroids in relation to sexual
and skeletal maturation in obese male adolescents. J Clin Endocrinol
Metab. 2014;99(8):2977-2985. https://doi.org/10.1210/jc.2014-
1452.
26. Mushannen T, Cortez P, Stanford FC, Singhal V. Obesity and hyp-
ogonadism—a narrative review ing the need for high-quality data in
adolescents. Children (Basel, Switzerland). 2019;6(5):63. https://doi.
org/10.3390/children6050063.
27. Nakamura Gang HX, Suzuki T, Sasano H, WEY R. Adrenal changes
associted with adrenarche. Rev Endocr Metab Disord. 2009;10:
19-26.
28. Auchus JR. The physiology and biochemistry of adrenarche. Endocr
Rev. 2011;20:20-27.
29. Weber Clark AJ, Perry LA, Honour JW, MOA S. Diminished adrenal
androgen secretion in familial glucocorticoid deficiency implicates a
significant role for ACTH in the induction of adrenarche. Clin
Endocrinol. 1997;46:431-437.
30. Boettcher Hartmann MF, de Lafolie J, Zimmer KP, SAC W. Absent
adrenarche in children with hypopituitarism: a study based on urinary
steroid metabolomics. Horm Res Pediatr. 2013;79:356-360.
31. Marakaki Karapanou O, Gryparis A, Hochberg Z, Chrousos G,
Papadimitriou AC. Early adiposity rebound and premature adre-
narche. J Pediatr. 2017;186:72-77.
32. de Ridder M, Thijssen JH, Bruning PF, van den JKL B, Zonderland ML,
WBC E. Body fat mass, body fat distribution, and pubertal develop-
ment: a longitudinal study of physical and hormonal sexual matura-
tion of girls. J Clin Endocrinol Metab. 1992;75:442-446.
33. Dunn F, Nisula BC, Rodbard DJ. Transport of steroid hormones:
binding of 21 endogenous steroids to both testosterone-binding
globulin and corticosteroid-binding globulin in human plasma. 1981;
53:58-68.
34. Mendelson R, Simpson ERC. Regulation of estrogen biosynthesis by
human adipose cells in vitro. Mol Cell Endocrinol. 1987;52:169-176.
35. MacDonald C, Madden JD, Brenner PF, Wilson JD, PKP S. Origin of
estrogen in normal men and in women with testicular feminization. J
Clin Endocrinol Metab. 1979;49:905-916.
36. O'Reilly MW, House PJ, Tomlinson JW. Understanding androgen
action in adipose tissue. J Steroid Biochem Mol Biol. 2014;143:
277-284.
37. Soeborg Fredericksen H, Fruekilde P, Johenssen TH, Juul A, AMT A.
Serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone,
Δ4-androstenedione and testosterone in children determiend by Tur-
boFlow-LC-MS/MS. Clin Chim Acta. 2013;419:95-101.
38. Meikle W, Kushnir MM, Rockwood AL, Pattison EG, Terry AH,
Sandrock TA. Adrenal steroid concentrations in children seven to
seventeen years of age. J Pediatr Endocrinol Metab. 2007;20:
1281-1291.
39. Soldin P, Sharma H, Husted L, Soldin SJO. Pediatric reference inter-
vals for aldosterone, 17α-hydroxyprogesterone, dehydroepiandros-
terone, testosterone and 25-hydroxy vitamin D3 using tandem mass
spectrometry. Clin Biochem. 2009;42:823-827.
40. Kushnir M, Blamires T, Rockwood AL, et al. Liquid chromatography—
Tandem Mass Spectrometry assay for Androstenedione, Dehydroepi-
androsterone, and Testosterone with pediatric and adult reference
intervals. Clin Chem. 2010;56:1138-1147.
41. Soeborg Fredericksen H, Mouritsen A, Johannsen TH, et al. Sex,
age, pubertal development and use of oral contraceptives in
relation to serum concentrations of DHEA, DHEAS, 17α-
hydroxyprogesterone, Δ4-androstenedione, testosterone and their
ratios in children, adolescents and young adults. Clin Chim Acta.
2014;437:6-13.
42. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ.
Insulin Stimulates androgen accumulation in incubations of ovarian
12 of 13 CHYNOWETH ET AL.
stroma obtained from women with hyperandrogenism. J Clin
Endocrinol Metab. 1986;62(5):904-910. https://doi.org/10.1210/
jcem-62-5-904.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Chynoweth J, Hosking J, Jeffery A,
Pinkney J. Contrasting impact of androgens on male and
female adiposity, fat distribution and insulin resistance in
childhood and adolescence (EarlyBird 75). Pediatric Obesity.
2020;e12685. https://doi.org/10.1111/ijpo.12685
CHYNOWETH ET AL. 13 of 13
